These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 1791768)
41. Risk of cardiovascular outcomes in users of estradiol/dydrogesterone or other HRT preparations. Schneider C; Jick SS; Meier CR Climacteric; 2009 Oct; 12(5):445-53. PubMed ID: 19565370 [TBL] [Abstract][Full Text] [Related]
42. The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium. Swahn ML; Johannisson E; Daniore V; de la Torre B; Bygdeman M Hum Reprod; 1988 Oct; 3(7):915-21. PubMed ID: 2846630 [TBL] [Abstract][Full Text] [Related]
43. Variable effects of RU 486 on endometrial maintenance in the luteal phase extended by exogenous hCG. Croxatto HB; Salvatierra AM; Croxatto HD; Spitz IM Clin Endocrinol (Oxf); 1989 Jul; 31(1):15-23. PubMed ID: 2598478 [TBL] [Abstract][Full Text] [Related]
44. The effect of transdermal oestradiol on bleeding pattern, hormonal profiles and sex steroid receptor distribution in the endometrium of Norplant users. Boonkasemsanti W; Reinprayoon D; Pruksananonda K; Niruttisard S; Triratanachat S; Leepipatpaiboon S; Wannakrairot P Hum Reprod; 1996 Oct; 11 Suppl 2():115-23. PubMed ID: 8982753 [TBL] [Abstract][Full Text] [Related]
45. [A "no-bleeding" substitute hormone treatment with an oral microdose progesterone. A prospective multicenter study]. Gillet JY; Faguer B; André G; Magnin G; de Lignières B; Philippe E J Gynecol Obstet Biol Reprod (Paris); 1994; 23(4):407-12. PubMed ID: 8051369 [TBL] [Abstract][Full Text] [Related]
46. [HRT in post-menopausal women: endometrial histology and bleeding patterns]. Lo Dico G; Alongi G; Spinelli MP; Cannariato P; Lucido AM Minerva Ginecol; 2002 Aug; 54(4):361-6. PubMed ID: 12114870 [TBL] [Abstract][Full Text] [Related]
47. [Hormone replacement therapy with 17 beta-estradiol dydrogesterone: results of a 3-month open-label study]. Grisar J; Travica S; Metka M; Pietschmann P Wien Klin Wochenschr; 1999 Dec; 111(24):1035-43. PubMed ID: 10677891 [TBL] [Abstract][Full Text] [Related]
48. Inhibitors and activation markers of the haemostatic system during hormone therapy: a comparative study of oral estradiol (2 mg)/ dydrogesterone and estradiol (2 mg)/ trimegestone. Norris LA; Brosnan J; Bonnar J; Conard J; Kluft C; Hellgren M Thromb Haemost; 2008 Aug; 100(2):253-60. PubMed ID: 18690345 [TBL] [Abstract][Full Text] [Related]
49. Long oestradiol replacement in an oocyte donation programme. Remohí J; Gutiérrez A; Cano F; Ruiz A; Simón C; Pellicer A Hum Reprod; 1995 Jun; 10(6):1387-91. PubMed ID: 7593502 [TBL] [Abstract][Full Text] [Related]
50. Effect of ultra-low-dose estradiol and dydrogesterone on arterial stiffness in postmenopausal women. Matsui S; Yasui T; Tani A; Kato T; Uemura H; Kuwahara A; Matsuzaki T; Arisawa K; Irahara M Climacteric; 2014 Apr; 17(2):191-6. PubMed ID: 24164272 [TBL] [Abstract][Full Text] [Related]
51. Endometrial effects, bleeding control, and compliance with a new postmenopausal hormone therapy regimen based on transdermal estradiol gel and every-other-day vaginal progesterone in capsules: a 3-year pilot study. Cicinelli E; de Ziegler D; Alfonso R; Nicoletti R; Bellavia M; Colafiglio G Fertil Steril; 2005 Jun; 83(6):1859-63. PubMed ID: 15950667 [TBL] [Abstract][Full Text] [Related]
53. Progesterone versus dehydrogesterone as replacement therapy in women with premature ovarian failure. Pellicer A; Matallín P; Miró F; Rivera J; Bonilla-Musoles FM Hum Reprod; 1989 Oct; 4(7):777-81. PubMed ID: 2606955 [TBL] [Abstract][Full Text] [Related]
54. Endometrial responses in artificial cycles: a prospective study comparing four different oestrogen dosages. Li TC; Cooke ID; Warren MA; Goolamallee M; Graham RA; Aplin JD Br J Obstet Gynaecol; 1992 Sep; 99(9):751-6. PubMed ID: 1329937 [TBL] [Abstract][Full Text] [Related]
55. Effect of chronic daily oral administration of 17 beta-oestradiol and norethisterone on the isoforms of serum gonadotrophins in post-menopausal women. Wide L; Naessén T; Phillips DJ Clin Endocrinol (Oxf); 1995 Jan; 42(1):59-64. PubMed ID: 7889633 [TBL] [Abstract][Full Text] [Related]
56. Effect of Oral versus Vaginal Administration of Estradiol and Dydrogesterone on the Proliferative and Secretory Transformation of Endometrium in Patients with Premature Ovarian Failure and Preparing for Assisted Reproductive Technology. Feng W; Nie L; Wang X; Yang F; Pan P; Deng X Drug Des Devel Ther; 2021; 15():1521-1529. PubMed ID: 33883876 [TBL] [Abstract][Full Text] [Related]
57. Oestrogen treatment for increased bleeding in Norplant users: preliminary results. Witjaksono J; Lau TM; Affandi B; Rogers PA Hum Reprod; 1996 Oct; 11 Suppl 2():109-14. PubMed ID: 8982752 [TBL] [Abstract][Full Text] [Related]
58. Glandular cystic hyperplasia of the endometrium in the perimenopausal years. Meden-Vrtovec H; Hren-Bozic M Acta Eur Fertil; 1988; 19(1):49-52. PubMed ID: 3414332 [TBL] [Abstract][Full Text] [Related]
59. Hormone replacement therapy with dydrogesterone and 17 beta-oestradiol: effects on serum lipoproteins and glucose tolerance during 24 month follow up. Crook D; Godsland IF; Hull J; Stevenson JC Br J Obstet Gynaecol; 1997 Mar; 104(3):298-304. PubMed ID: 9091005 [TBL] [Abstract][Full Text] [Related]
60. Hormone replacement therapy may reduce high serum homocysteine in postmenopausal women. van der Mooren MJ; Wouters MG; Blom HJ; Schellekens LA; Eskes TK; Rolland R Eur J Clin Invest; 1994 Nov; 24(11):733-6. PubMed ID: 7890010 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]